Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2007 1
2008 4
2009 1
2010 2
2011 2
2012 6
2013 5
2014 2
2015 5
2016 5
2017 7
2018 11
2019 5
2020 5
2021 6
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Revised international prognostic scoring system for myelodysplastic syndromes.
Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Malcovati L, Cazzola M, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M, Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilstöcker M, Sekeres M, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D. Greenberg PL, et al. Blood. 2012 Sep 20;120(12):2454-65. doi: 10.1182/blood-2012-03-420489. Epub 2012 Jun 27. Blood. 2012. PMID: 22740453 Free PMC article.
Metabolic syndrome: A patient-related prognostic factor for cancer?
Mendonça PDS, Aguiar APN, Pinheiro RF, Magalhães SMM. Mendonça PDS, et al. Among authors: magalhaes smm. J Cancer Res Ther. 2022 Jul-Sep;18(4):1210-1211. doi: 10.4103/jcrt.JCRT_323_19. J Cancer Res Ther. 2022. PMID: 36149193 Free article. No abstract available.
ERVs-TLR3-IRF axis is linked to myelodysplastic syndrome pathogenesis.
de Oliveira RTG, Cordeiro JVA, Vitoriano BF, de Lima Melo MM, Sampaio LR, de Paula Borges D, Magalhães SMM, Pinheiro RF. de Oliveira RTG, et al. Among authors: magalhaes smm. Med Oncol. 2021 Feb 17;38(3):27. doi: 10.1007/s12032-021-01466-1. Med Oncol. 2021. PMID: 33594613
It is not just the number of metaphases that matters.
Costa MB, Borges DP, Melo MML, Magalhães SMM, Pinheiro RF. Costa MB, et al. Among authors: magalhaes smm. Leuk Res. 2018 May;68:70-71. doi: 10.1016/j.leukres.2018.02.018. Epub 2018 Mar 1. Leuk Res. 2018. PMID: 29567493 No abstract available.
Role of the STING pathway in myeloid neoplasms: a prospero-registered systematic review of principal hurdles of STING on the road to the clinical practice.
Sampaio LR, Dias RDB, Goes JVC, de Melo RPM, de Paula Borges D, de Lima Melo MM, de Oliveira RTG, Ribeiro-Júnior HL, Magalhães SMM, Pinheiro RF. Sampaio LR, et al. Among authors: magalhaes smm. Med Oncol. 2024 Apr 24;41(6):128. doi: 10.1007/s12032-024-02376-8. Med Oncol. 2024. PMID: 38656461 Review.
Erdheim-Chester disease after Essential Thrombocythemia: coincidence or not?
Silveira LHJ, Nogueira CD, Costa CT, de Azevedo PT, Magalhães SMM, Pinheiro RF. Silveira LHJ, et al. Among authors: magalhaes smm. Hematol Transfus Cell Ther. 2023 Jan-Mar;45(1):90-94. doi: 10.1016/j.htct.2021.01.013. Epub 2021 May 2. Hematol Transfus Cell Ther. 2023. PMID: 34034993 Free PMC article. No abstract available.
Observational study of multiple myeloma in Latin America.
Hungria VT, Maiolino A, Martinez G, Duarte GO, Bittencourt R, Peters L, Colleoni G, Oliveira LC, Crusoé E, Coelho ÉO, Pasquini R, Magalhães SM, Nunes R, Neto JV, Faria RM, Souza M, Hamerschlak N, Flantl D, Navarro JR, Conte G, Gomez-Almaguer D, Ruiz-Argüelles G, Durie BG; International Myeloma Working Group Latin America. Hungria VT, et al. Ann Hematol. 2017 Jan;96(1):65-72. doi: 10.1007/s00277-016-2866-9. Epub 2016 Nov 5. Ann Hematol. 2017. PMID: 27815724
60 results